Breaking News Instant updates and real-time market news.

NVLN

Novelion Therapeutics

$2.02

0.07 (3.59%)

, ACPW

Active Power

08:30
12/01/16
12/01
08:30
12/01/16
08:30

Two new option listings and three option delistings on December 1st

New option listings for December 1st include Novelion Therapeutics Inc (NVLN) and Active Power Inc (PIOI). Option delistings effective December 1st include Active Power Inc (ACPW), Aegerion Pharmaceuticals Inc (AEGR), and QLT Inc (QLTI).

NVLN

Novelion Therapeutics

$2.02

0.07 (3.59%)

ACPW

Active Power

AEGR

Changed to NVLN

QLTI

Changed to NVLN

NVLN Novelion Therapeutics
$2.02

0.07 (3.59%)

ACPW Active Power

02/25/16
ROTH
02/25/16
DOWNGRADE
Target $1
ROTH
Neutral
Active Power assumed with a Neutral from Buy at Roth Capital
Roth Capital analyst Craig Irwin downgraded Active Power to Neutral from Buy after assuming coverage of the name. The analyst cut his price target for the shares to $1 from $3. Irwin cites "choppiness" in the company's revenue and bookings progression.
AEGR Changed to NVLN

02/12/16
02/12/16
DOWNGRADE

On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Aegerion (AEGR) downgraded to Underperform from Neutral at BofA/Merrill... Archer Daniels (ADM) downgraded to Hold from Buy at Argus... Bed Bath & Beyond (BBBY) downgraded to Perform from Outperform at Oppenheimer... Best Buy (BBY) downgraded to Perform from Outperform at Oppenheimer... Boeing (BA) downgraded to Neutral from Overweight at JPMorgan... CSX (CSX) downgraded to Market Perform from Outperform at Avondale... Comstock Resources (CRK) downgraded to Neutral from Buy at Ladenburg... EV Energy (EVEP) downgraded to Neutral from Buy at Ladenburg... FNFV (FNFV) downgraded to Market Perform from Outperform at Keefe Bruyette... Flowers Foods (FLO) downgraded to Hold from Buy at Deutsche Bank... Goldcorp (GG) downgraded to Sector Performer from Outperformer at CIBC... Group 1 Automotive (GPI) downgraded to Sector Weight from Overweight at KeyBanc... HSBC cuts Sprint (S) to sell, says competitors may make turnaround difficult... KAR Auction (KAR) downgraded to Neutral from Buy at Goldman... LINN Energy (LINE) downgraded to Sell from Neutral at Citi... LPL Financial (LPLA) downgraded to Market Perform from Outperform at Wells Fargo... Legacy Reserves (LGCY) downgraded to Neutral from Buy at Ladenburg... LinnCo (LNCO) downgraded to Sell from Neutral at Citi... Memorial Production (MEMP) downgraded to Neutral from Buy at Ladenburg... NetApp (NTAP) downgraded to Underweight from Neutral at Atlantic Equities... Netflix (NFLX) downgraded to Market Perform from Outperform at FBR Capital... Nu Skin (NUS) downgraded to Neutral from Buy at Sidoti... Oceaneering (OII) downgraded on multiple headwinds at RBC Capital... Och-Ziff Capital (OZM) downgraded to Neutral from Buy at Compass Point... Stone Energy (SGY) downgraded to Neutral from Buy at Ladenburg... Vanguard Natural (VNR) downgraded to Neutral from Buy at Ladenburg.
02/26/16
LEER
02/26/16
NO CHANGE
Target $15
LEER
Outperform
Aegerion price target lowered to $15 from $31 at Leerink
Leerink analyst Joseph Schwartz cut his price target for Aegerion Pharmaceuticals to $15 citing the "flat-to-declining" trajectory of Juxtapid following the company's Q4 results. The 2016 Juxtapid guidance is disappointing but Myalept remains a bright spot, Schwartz tells investors in a post-earnings research note. He keeps an Outperform rating on Aegerion.
05/17/16
LEER
05/17/16
NO CHANGE
Target $6
LEER
Outperform
Aegerion price target lowered to $6 from $15 at Leerink
Leerink analyst Joseph Schwartz lowered his price target for Aegerion to $6 from $15 after the company revised downward 2016 guidance given its Juxtapid's low revenue in Q1 leading to a top- and bottom-line miss and indications of weakness going forward. The analyst reiterates an Outperform rating on the shares.
11/11/16
JPMS
11/11/16
INITIATION
JPMS
Neutral
Aegerion resumed with a Neutral at JPMorgan
JPMorgan analyst Jessica Fye resumed coverage of Aegerion Pharmaceuticals with a Neutral rating. The analyst views 2016 as a "show me" year for the company given the "continued substantial impact to the Juxtapid franchise from the PCSK9s."
QLTI Changed to NVLN

TODAY'S FREE FLY STORIES

RF

Regions Financial

$18.15

-0.21 (-1.14%)

06:00
01/19/18
01/19
06:00
01/19/18
06:00
Earnings
Regions Financial reports Q4 cont ops EPS 27c, consensus 26c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

MWA

Mueller Water

$12.28

-0.06 (-0.49%)

05:59
01/19/18
01/19
05:59
01/19/18
05:59
Downgrade
Mueller Water rating change  »

Cowen downgrades Mueller…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

  • 22

    Feb

OBLN

Obalon Therapeutics

$6.14

-0.725 (-10.56%)

05:57
01/19/18
01/19
05:57
01/19/18
05:57
Syndicate
Obalon Therapeutics 5.455M share Secondary priced at $5.50 »

UBS, Canaccord and Stifel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 19

    Jan

GDEN

Golden Entertainment

$28.21

-0.6 (-2.08%)

05:56
01/19/18
01/19
05:56
01/19/18
05:56
Syndicate
Golden Entertainment 6.5M share Secondary priced at $28.00 »

JPMorgan and Morgan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

AGIO

Agios Pharmaceuticals

$68.15

-2.18 (-3.10%)

05:56
01/19/18
01/19
05:56
01/19/18
05:56
Syndicate
Agios Pharmaceuticals 7.09M share Secondary priced at $67.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 19

    Jan

AAPL

Apple

$179.26

0.16 (0.09%)

05:55
01/19/18
01/19
05:55
01/19/18
05:55
Periodicals
S. Korean consumer group files criminal complaint against Apple CEO, CNBC says »

South Korean consumer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

AVT

Avnet

$41.32

-0.33 (-0.79%)

05:54
01/19/18
01/19
05:54
01/19/18
05:54
Upgrade
Avnet rating change  »

Avnet upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

FCAU

Fiat Chrysler

$23.40

0.28 (1.21%)

05:54
01/19/18
01/19
05:54
01/19/18
05:54
Upgrade
Fiat Chrysler rating change  »

Fiat Chrysler upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DANOY

Danone

$17.06

0.085 (0.50%)

05:54
01/19/18
01/19
05:54
01/19/18
05:54
Upgrade
Danone rating change  »

Danone upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WNS

WNS Holdings

$45.28

2.31 (5.38%)

05:53
01/19/18
01/19
05:53
01/19/18
05:53
Downgrade
WNS Holdings rating change  »

WNS Holdings downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BK

BNY Mellon

$55.35

-2.54 (-4.39%)

05:53
01/19/18
01/19
05:53
01/19/18
05:53
Upgrade
BNY Mellon rating change  »

BNY Mellon upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

CRBP

Corbus Pharmaceuticals

$7.95

-0.25 (-3.05%)

05:52
01/19/18
01/19
05:52
01/19/18
05:52
Initiation
Corbus Pharmaceuticals initiated  »

Corbus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESS

Essex Property Trust

$224.60

-2.76 (-1.21%)

05:49
01/19/18
01/19
05:49
01/19/18
05:49
Downgrade
Essex Property Trust rating change  »

Essex Property Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

GPN

Global Payments

, FDC

First Data

$17.56

-0.04 (-0.23%)

05:48
01/19/18
01/19
05:48
01/19/18
05:48
Recommendations
Global Payments, First Data, Worldpay analyst commentary  »

Global Payments price…

GPN

Global Payments

FDC

First Data

$17.56

-0.04 (-0.23%)

WP

Worldpay

$79.08

1.19 (1.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

  • 01

    Mar

MWA

Mueller Water

$12.28

-0.06 (-0.49%)

05:48
01/19/18
01/19
05:48
01/19/18
05:48
Downgrade
Mueller Water rating change  »

Mueller Water downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

  • 22

    Feb

CUB

Cubic

$59.95

-0.8 (-1.32%)

05:48
01/19/18
01/19
05:48
01/19/18
05:48
Downgrade
Cubic rating change  »

Cubic downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jun

VEOEY

Veolia Environment

$25.50

-0.285 (-1.11%)

05:46
01/19/18
01/19
05:46
01/19/18
05:46
Upgrade
Veolia Environment rating change  »

Veolia Environment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAA

MAA

$91.54

-1.33 (-1.43%)

05:45
01/19/18
01/19
05:45
01/19/18
05:45
Upgrade
MAA rating change  »

MAA upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

SIEN

Sientra

$10.33

-0.71 (-6.43%)

05:45
01/19/18
01/19
05:45
01/19/18
05:45
Upgrade
Sientra rating change  »

Sientra upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

CMG

Chipotle

$337.53

2.9 (0.87%)

05:43
01/19/18
01/19
05:43
01/19/18
05:43
Upgrade
Chipotle rating change  »

Chipotle upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

PLYA

Playa Hotels & Resorts

$10.75

-0.56 (-4.95%)

05:42
01/19/18
01/19
05:42
01/19/18
05:42
Recommendations
Playa Hotels & Resorts analyst commentary  »

Playa selloff yesterday a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

05:40
01/19/18
01/19
05:40
01/19/18
05:40
General news
The IEA forecasts crude supply to increase in 2018 »

The IEA forecasts crude…

SQ

Square

$40.27

0.21 (0.52%)

05:40
01/19/18
01/19
05:40
01/19/18
05:40
Recommendations
Square analyst commentary  »

Square price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jan

CLF

Cleveland-Cliffs

$8.41

-0.08 (-0.94%)

05:36
01/19/18
01/19
05:36
01/19/18
05:36
Initiation
Cleveland-Cliffs initiated  »

Cleveland-Cliffs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

NFLX

Netflix

$220.33

2.83 (1.30%)

05:33
01/19/18
01/19
05:33
01/19/18
05:33
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 30

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.